TAG-72, also known as Tumor-Associated Glycoprotein 72, is a glycoprotein primarily found on the surface of various cancer cells. Its function is intimately connected with cellular adhesion and communication within the context of cancer biology. TAG-72 plays a pivotal role in facilitating cell-cell interactions, particularly between cancer cells and surrounding tissues. This glycoprotein acts as a molecular adhesive, allowing cancer cells to adhere to nearby cells and extracellular matrices. Such adhesive properties are essential for tumor invasion, metastasis, and the formation of solid tumors.
Inhibition of TAG-72 involves the disruption of these critical adhesive interactions. Various mechanisms can hinder TAG-72's function, ultimately impeding cancer cell adhesion and metastasis. While the precise details of these mechanisms can vary, they typically involve the interference with molecular interactions necessary for TAG-72's adhesive properties. This may include the development of agents that competitively bind to TAG-72, preventing its engagement with other cellular components. Alternatively, inhibition strategies may target downstream signaling pathways triggered by TAG-72, disrupting the cascades responsible for cancer cell adhesion and metastasis. By inhibiting TAG-72, these approaches aim to hinder the ability of cancer cells to form tumors, invade surrounding tissues, and spread to distant sites.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine, a known autophagy inhibitor, can lead to the accumulation of glycoproteins in the endoplasmic reticulum, potentially reducing the trafficking of TAG-72 to the membrane and its subsequent expression. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the Golgi apparatus, where glycoproteins like TAG-72 undergo post-translational modifications; this can impair TAG-72's maturation and export to the cell surface. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $138.00 $251.00 $631.00 $815.00 $1832.00 | 6 | |
As an inhibitor of Golgi alpha-mannosidase II, swainsonine can alter glycosylation patterns of proteins like TAG-72, potentially decreasing its stability and functionality. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
Castanospermine inhibits glycosidase enzymes, which could disrupt the glycosylation of TAG-72, affecting its folding and transport to the cell surface. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin, a sodium ionophore that disrupts Golgi function, could reduce the proper glycosylation and trafficking of TAG-72, indirectly reducing its expression. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin blocks N-linked glycosylation, which could inhibit proper folding and stability of TAG-72, thus potentially decreasing its levels. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $73.00 $145.00 | ||
This glycosidase inhibitor can alter the glycosylation status of TAG-72, impacting its structure and possibly reducing its cellular levels. | ||||||
Kifunensine | 109944-15-2 | sc-201364 sc-201364A sc-201364B sc-201364C | 1 mg 5 mg 10 mg 100 mg | $135.00 $540.00 $1025.00 $6248.00 | 25 | |
Kifunensine inhibits mannosidase I in the ER, which could affect the maturation of glycoproteins such as TAG-72 and its subsequent function. | ||||||